Clinical Decision Support Systems (CDSS) Market Size, Share & Trends Analysis Report By Product, By Application (Allery Alert, Dosing Support), By Delivery Mode (On-premise, Cloud, Web), By Component, And Segment Forecasts, 2018 - 2024

Report Overview

The global clinical decision support systems (CDSS) market size was valued at USD 471.96 million in 2016. Rising demand for quality care and integrated reliable technical solutions is one of the key trends escalating market growth. Increasing adoption of information systems by hospitals and healthcare institutes and favorable initiatives taken by several governments worldwide are also stimulating the growth of the market. 

Clinical decision support systems (CDSS) are strictly regulated by authorities such as FDA. Therefore, platforms introduced or in developmental phases are expected to fulfill relevant criteria set by FDA & CE Mark. In addition, competitors have to take into account non-violation of information technology and cyber laws to assure products’ integrity.

Rapid advancements in the fields of biotechnology and bioinformatics are encouraging improvements and optimizations in data storage, management, and analytics platforms. The marketplace is anticipated to witness a large number of innovations following R&D projects backed up by large corporate investments. Integration of cloud computing and interoperability platforms in different systems will further promote smooth functioning and seamless dataflow, thereby revving up the adoption of CDSS.

Significant increase in the number of hospitals and healthcare facilities adopting various forms and levels of clinical decision support systems in recent times provides a significant potential for increased near-future implementation. Demand for decision support based on factual evidence and real-time knowledge has grown faster in developed regions. CDSS simplifies physical order entry by allowing physicians to make choice of prescription from its database. Rising number of patients visiting clinics and hospitals has increased the challenges to maintain and manage data for every patient.

Growing focus on quality care and precision medicine in these regions is also projected to fuel revenue generation. Clinical and drug related data stored on cloud can be accessed only by authorized users. Integration with Electronic Health Record (EHR) improves the efficiency of clinical care by reducing the time to search for patient’s history and clinical records.

Over the past few years, emergence of collaborations among CDSS providers and hospitals has witnessed significant increase. Companies are involved in partnerships to develop and provide software updated with latest information. Government recognition and initiatives to encourage adoption of CDSS and EHR systems are estimated to further increase demand.

Product Insights

CDSS products are available either in standalone or in integration with EHR or CPOE or both. Standalone CDSS is widely adopted due to low cost and simplicity. Ease to use in hospitals and clinical settings has contributed to its highest share. The standalone segment will continue to dominate the market throughout the forecast horizon.

Increasing awareness and adoption of EHR by multi-specialty health care units is poised to influence share of CDSS integrated with EHR. However, clinical decision support systems integrated with CPOE is likely to witness the fastest growth during the forecast period. This can be attributed to adoption of computerized prescription patterns in developed regions.

Application Insights

CDSS provides results that predict drug interaction and patient’s response on being administered a particular dosage. It, thus, helps practitioner to make an appropriate decision for treatment. The system, when entered with patient’s history and medical records, provides a list of options for the further course of medication and helps practitioners.

It provides a list of possible drug allergies for a particular drug or a combination of drugs being prescribed. Furthermore, it gives a list of possible drug-drug interactions that alert about possible reactions for the combination of drugs being prescribed, thereby preventing side effects or adverse drug reactions.

CDSS offers clinical reminders to patients for their appointments and medications. In addition, it has clinical guidelines stored in it, which provides decision-making support for drug dosage and medication.

Drug allergy alerts dominated the market in 2016. However, with rising number of drug combinations, drug dosing support is expected to witness the fastest growth over the forecast period.

Delivery Mode Insights

Only authorized users can access CDSS over the cloud, on web, or on hospital/clinic premise. On-premise delivery systems are widely adopted due to privacy and information safety issues. These systems will be the leading revenue contributor in the global arena throughout the forecast period.

Medical data available has increased by many folds with constant rise in number of innovations. FDA approvals for novel combinations of treatment of complicated health conditions such as cancer and neurodegeneration have increased in last few years. Storage and handling of data on such a large scale become difficult for individual systems. Thus, cloud delivery is projected to witness boost in demand. 

Component Insights

Key components of CDSS are software, hardware, and services by providers of the system. The hardware includes computer and other electronic gadgets used to run the software; the software component performs data analysis and provides decision support to organization; and the services involve maintenance, upgrading, and troubleshooting for both the hardware as well as the software by the provider.

CDSS services are poised to witness lucrative growth during the forecast period. This is due to timely upgradation of software as well as knowledge base available for use. High cost is associated with premium access to the latest and accurate data, which is likely to influence revenue generation for the segment positively.

Regional Insights

North America dominated the CDSS market in 2016. Surging demand for healthcare information technology solutions in the medical sector is expected to propel the regional market. Rapid technological advancements and growing emphasis on quality healthcare services are contributing to the growth of the region.

Asia Pacific, on the other handed, is anticipated to be the fastest growing region, owing to increasing investments in the healthcare sector in countries such as Australia, China, India, and Singapore. The CAGR for this market is estimated to be about 8.0% during the forecast period.

Key Companies & Market Share Insights

Some of the companies operating in the market are Agfa Healthcare; McKesson Corporation; NextGen Healthcare Information Systems; Medical Information Technology Inc.; Carestream Health Inc.; AthenaHealth; Philips Healthcare; Wolters Kluwer NU; Cerner Corporation; and Siemens Healthineers. Market players are entering into licensing deals with leading hospitals and healthcare groups to expand their consumer base. For instance, Assistance Publique - Hopitaux de Paris (AP-HP) extended its seven-year contract for another four years. This contract involved the deployment of ORBIS modules at all the hospitals of AP-HP.

In March 2016, Lawrence Memorial Healthcare of New London signed a contract with Carestream for its clinical collaboration platform. Similarly, Philips Healthcare signed an agreement of collaboration with Valdic in February 2016. Increasing number of these collaborations is projected to propel the market.

Clinical Decision Support Systems Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at regional & country level and provides an analysis of industry trends in each of the sub-segments from 2013 to 2024. For the purpose of this report, Grand View Research has segmented the global clinical decision support systems (CDSS) market report on the basis of product, application, delivery mode, component, and region:

• Product Outlook (Revenue, USD Million, 2013 - 2024)

  • Standalone CDSS

  • Integrated CPOE with CDSS

  • Integrated E.H.R. with CDSS

  • Integrated CDSS with CPOE & E.H.R.

• Application Outlook (Revenue, USD Million, 2013 - 2024)

  • Drug-drug interactions

  • Drug allergy alerts

  • Clinical reminders

  • Clinical guidelines

  • Drug dosing support

  • Others

• Delivery Mode Outlook (Revenue, USD Million, 2013 - 2024)

  • Web Delivery

  • Cloud Delivery

  • On Premises Delivery

• Component Outlook (Revenue, USD Million, 2013 - 2024)

  • Hardware

  • Software

  • Services

• Regional Outlook (Revenue, USD Million, 2013 - 2024)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

  • Asia Pacific

    • Japan

    • China

  • Latin America

    • Brazil

  • Middle East and Africa (MEA)

    • South Africa